Notícias 23andMe Holding Company - ME | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
23andMe Holding Company (ME)
23andMe Holding Company (ME) Notícias

23andMe Holding Company (ME)

3,84

-0,21

(-5,19%)

Fechado 12 Janeiro 6:00PM

Atrasado por 15 minutos

3,84

0,01

(0,26%)

Após o horário de negociação: 7:00PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology

Form 4 - Statement of changes in beneficial ownership of securities

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

23andMe to Report Q2 FY2025 Financial Results

Form 8-K - Current report

23andMe Regains Compliance With Nasdaq Listing Requirements

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 8-K - Current report

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

NLBNPIT1VI31 20991231 16...

Newbury Racecourse

BNP Paribas Issuance

GraniteShares 3x Long MI...

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições